Impact of Combined “CHADS-BLED” Score to Predict Short-Term Outcomes in Transfemoral and Transapical Aortic Valve Replacement

Figure 1

Kaplan–Meier survival curves for 30-day mortality and adverse event rates according to high and low combined CHADS-BLED score. (a) Kaplan–Meier survival curves according to the combined CHADS-BLED score in TF TAVR and (b) TA TAVR patients. (c) Awarding of adverse event rates according to high and low combined CHADS-BLED score in TF TAVR and (d) TA TAVR patients.

(a)

(b)

(c)

(d)